Cabaletta Bio (CABA) Total Current Liabilities (2018 - 2026)
Cabaletta Bio's Total Current Liabilities was $39.91 million in Q2 2026, down 3.9% from $41.54 million a year earlier.
Powered by 
Analysis
Cabaletta Bio (CABA) Total Current Liabilities (2018 - 2026) Analysis & Trends
At the end of FY2025, Total Current Liabilities at Cabaletta Bio came in at $50.15 million, up 85.2% from FY2024.
- Total Current Liabilities has now increased for seven consecutive years, with a five-year compound annual growth rate of 57.5% (FY2020 to FY2025).
- In earlier years, Total Current Liabilities was $27.09 million in FY2024 (+69.4%), $15.99 million in FY2023 (+68.6%), $9.49 million in FY2022 (+13.2%) and $8.38 million in FY2021 (+61.8%).
- The Q2 2026 figure marks the lowest quarterly Total Current Liabilities since Q1 2025.
- Compared with a year earlier, Total Current Liabilities was higher in six of the last seven quarters, with growth averaging 83.9%.
- The best year-over-year quarter for Total Current Liabilities over five years was Q2 2025 (growth of 132.1%); the worst was Q2 2026 (a decline of 3.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.94 Bn |
| 10 | Cabaletta Bio | 339.09 Mn | 339.09 Mn | - | 39.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.91 Mn |
| Dec 31, 2025 | 50.15 Mn |
| Sep 30, 2025 | 45.74 Mn |
| Jun 30, 2025 | 41.54 Mn |
| Mar 31, 2025 | 33.99 Mn |
| Dec 31, 2024 | 27.09 Mn |
| Sep 30, 2024 | 22.88 Mn |
| Jun 30, 2024 | 17.90 Mn |
| Mar 31, 2024 | 17.97 Mn |
| Dec 31, 2023 | 15.99 Mn |
| Sep 30, 2023 | 10.62 Mn |
| Jun 30, 2023 | 8.48 Mn |
| Mar 31, 2023 | 9.31 Mn |
| Dec 31, 2022 | 9.49 Mn |
| Sep 30, 2022 | 5.80 Mn |
| Jun 30, 2022 | 6.49 Mn |
| Mar 31, 2022 | 6.94 Mn |
| Dec 31, 2021 | 8.38 Mn |
| Sep 30, 2021 | 6.02 Mn |
| Jun 30, 2021 | 5.60 Mn |
API Access
Cabaletta Bio Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=CABA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "CABA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=CABA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();